ARCHIVES

New Drug Approvals Point To Greater Role Of Randomization In Cancer Clinical Trials. European Standards Will Demand More Rigor.

This article is from The Cancer Letter archive.

Vol. 32 No. 07 | February 24, 2006

Download PDF Visit The Full Archive

Related Articles

Adherez Issued U.S. Patent for Catenin Molecule Inhibition.

July 4, 2003

New Food Services Contractor Takes Over NIH Cafeterias.

July 14, 2000

Yates Named DRCCA AD To Head Centers, CCOP, Organ Sites: CCOP Workshops Listed

February 26, 1982

Organ Systems Program to Submit 10 More Concepts In Fall

July 10, 1987

Healy, Kessler Lose Jobs In Last-Minutes Maneuver By Bush White House To Defy Clinton Request

January 22, 1993

Obey Again – Now He’s Blasting NCI For Not Helping NIOSH

September 17, 1976